The COVID-19 pandemic and upgrades of CI speech processors for children: part II-hearing outcomes.
Eur Arch Otorhinolaryngol
; 279(10): 4815-4823, 2022 Oct.
Article
in English
| MEDLINE | ID: covidwho-1739321
ABSTRACT
PURPOSE:
To gauge the benefits to children of upgrading speech processors during the COVID-19 pandemic.METHODS:
The study involved 297 children, aged from 7.3 to 18.0 years, whose processors were upgraded to either Nucleus 7 or Kanso 2, or to Sonnet 2 or Rondo 3. To document the benefits of the upgrades, a speech-in-noise discrimination test and Patient Reported Outcome Measures (PROMs) were used.RESULTS:
There was a significant benefit from the newer processors in terms of speech discrimination in noise. Patient Reported Outcome Measures (PROMs) indicated less hearing disability, a higher level of functioning in everyday life situations, and more satisfaction with the new speech processor in social situations.CONCLUSION:
There is a measurable improvement in performance when the devices are upgraded to the new technology.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Speech Perception
/
Cochlear Implants
/
Cochlear Implantation
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Child
/
Humans
Language:
English
Journal:
Eur Arch Otorhinolaryngol
Journal subject:
Otolaryngology
Year:
2022
Document Type:
Article
Affiliation country:
S00405-022-07324-8
Similar
MEDLINE
...
LILACS
LIS